Neus Baste
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Randomized non-comparative phase II trial of nivolumab plus paclitaxel in subjects with recurrent/metastatic head and neck squamous cell carcinoma unable for cisplatin-based chemotherapy. NIVOTAX TTCC study.
Journal: European journal of cancer (Oxford, England : 1990)
Published: January 02, 2026
An observational retro-prospective study on patients with head and neck cancer who contracted COVID-19 (HERODOTUS: head and neck cancERs international cOviD-19 collabOraTion).
Journal: Oral oncology
Published: November 09, 2025
An observational retro-prospective study on patients with head and neck cancer who contracted COVID-19 (HERODOTUS: head and neck cancERs international cOviD-19 collabOraTion).
Journal: Oral oncology
Published: November 09, 2025
Durvalumab plus tremelimumab for the treatment of patients with progressive, refractory advanced thyroid carcinoma: the phase II GETNE-DUTHY trial.
Journal: Nature communications
Published: August 18, 2025
Cancer stem cell biomarkers in locally advanced head and neck squamous cell carcinoma.
Journal: Brazilian journal of otorhinolaryngology
Published: December 13, 2024
Blood-based prognostic scores and early dynamics under immunotherapy to select patients with metastatic solid tumors for continuing immune check-point inhibition: a prospective longitudinal study.
Journal: Cancer immunology, immunotherapy : CII
Published: September 24, 2024
Sex differences in laryngeal cancer treated with CO2-transoral laser microsurgery: a case-control study.
Journal: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
Published: September 17, 2024
SEOM-GETNE-TTCC Clinical guideline thyroid cancer (2023).
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: September 12, 2024
Correction to: Determinants of activity and efficacy of anti-PD1/PD-L1 therapy in patients with advanced solid tumors recruited in a clinical trials unit: a longitudinal prospective biomarker-based study.
Journal: Cancer immunology, immunotherapy : CII
Published: February 22, 2023
Pembrolizumab With or Without Chemotherapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Updated Results of the Phase III KEYNOTE-048 Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 11, 2022
Determinants of activity and efficacy of anti-PD1/PD-L1 therapy in patients with advanced solid tumors recruited in a clinical trials unit: a longitudinal prospective biomarker-based study.
Journal: Cancer immunology, immunotherapy : CII
Published: September 06, 2022
Last Updated: 09/26/2026